Swedish Body Project for Prevention of Eating Disorders (sBodyProject)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02567890|
Recruitment Status : Active, not recruiting
First Posted : October 5, 2015
Last Update Posted : November 8, 2017
|Condition or disease||Intervention/treatment||Phase|
|Eating Disorders||Behavioral: Internet-based DBI Behavioral: Expressive writing||Not Applicable|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||443 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||An Interactive Internet-based Program for Prevention of Eating Disorders on a Broad Basis|
|Study Start Date :||September 2015|
|Estimated Primary Completion Date :||December 2018|
|Estimated Study Completion Date :||December 2018|
Experimental: Internet-based DBI
Internet-based DBI, which consists of four interactive occasions, some homework assignments, and monitoring
Behavioral: Internet-based DBI
Participants will go through a four week interactive program that will improve body acceptance. Includes some homework assignments and monitoring.
Other Name: sBody Project
Placebo Comparator: Expressive writing
Expressive Writing (placebo/attention control) where participants write texts. This is the active control condition.
Behavioral: Expressive writing
Participants will be asked to reflect upon issues related to body image.
No Intervention: Waiting list
A wait-list control condition.Those in the wait-list condition will not receive any treatment until they have done the 6-month follow-up assessment.
- Change in the occurrence of Eating disorder diagnosis [ Time Frame: 6 12, 18 and 24 months after the completed intervention that lasts 4 weeks ]Diagnostic interview to establish the diagnoses of eating disorders
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02567890
|Solna, Sweden, 17177|
|Principal Investigator:||Ata Ghaderi, PhD||Karolinska Institutet|